Skip to main content

Table 2 Characteristics of patients meeting ACR and/or AECG criteria for Sjögren’s syndrome

From: Level of agreement between 2002 American–European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren’s syndrome and reasons for discrepancies

 

Patients fulfilling

 

Both sets

ACR set only

AECG set only

Neither set

 

(n = 27)

(n = 8)

(n = 15)

(n = 55)

Age (years)

60.7 ± 11.7

46.6 ± 15.8

59.3 ± 11.1

56.4 ± 14.5

Symptom duration (years)

9.5 ± 7.4

2.9 ± 2.4

4.7 ± 4.3

6.4 ± 5.7

Female

25 (92.6)

8 (100)

14 (93.3)

52 (94.5)

Xerophthalmia

26 (96.3)

6 (75.0)

14 (93.3)

50 (90.9)

Xerostomia

27 (100)

6 (75.0)

15 (100)

51 (92.7)

Salivary flow ≤0.1 ml/minute

18 (66.7)

0 (0)

10 (66.7)

16 (29.1)

Schirmer’s test ≤5 mm/5 minutes

22 (81.5)

1 (12.5)

12 (80.0)

13 (23.6)

OSS ≥3

24 (88.9)

6 (75.0)

0 (0)

19 (34.5)

Anti-SSA or anti-SSB positivity

18 (66.7)

4 (50.0)

4 (26.7)

1 (1.8)

ANA ≥1:320

25 (92.6)

5 (62.5)

8 (53.3)

18 (32.7)

RF positivity

14 (51.9)

4 (50.0)

1 (6.7)

6 (10.9)

Anti-SSA/SSB or RF plus ANA ≥1:320

21 (77.8)

4 (50.0)

4 (26.7)

1 (1.8)

Focus score ≥1

24 (88.9)

7 (87.5)

11 (73.3)

6 (10.9)

  1. Data presented as mean ± standard deviation or number (%). Xerophthalmia and xerostomia referred to subjective complaints from the patients. ACR, American College of Rheumatology; AECG, American–European Consensus Group; OSS, ocular staining score; ANA, antinuclear antibody; RF, rheumatoid factor.